Advertisement
Screener

REGENERON PHARMACEUTICALS, INC. (REGN) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

REGENERON PHARMACEUTICALS, INC. Earnings Per Share (Basic)

REGENERON PHARMACEUTICALS, INC. (REGN) reported Earnings Per Share (Basic) of $12.62 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-07-30

  • REGENERON PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was $12.62, a 4.68% decline year-over-year.
  • REGENERON PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was $6.99, a 7.78% decline year-over-year.
  • REGENERON PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-12-31 was $8.19, a 3.95% decline year-over-year.
  • REGENERON PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was $14.09, a 13.63% increase year-over-year.
  • REGENERON PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was $43.07, a 5.31% increase from fiscal 2024.
  • REGENERON PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was $40.90, a 10.39% increase from fiscal 2023.
  • REGENERON PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was $37.05, a 8.54% decline from fiscal 2022.
  • REGENERON PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was $40.51, a 46.98% decline from fiscal 2021.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 3 month as first filedEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 6 month as first filedEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 9 month as first filedEarnings Per Share, Basic 12 monthEarnings Per Share, Basic 12 month as first filed
2026-06-30$12.62
10-Q · filed 2026-07-30
$19.58
10-Q · filed 2026-07-30
$27.77
derived: net income ÷ weighted average shares · filed 2026-07-30
$41.87
derived: net income ÷ weighted average shares · filed 2026-07-30
2026-03-31$6.99
10-Q · filed 2026-04-29
$15.18
derived: net income ÷ weighted average shares · filed 2026-07-30
$29.27
derived: net income ÷ weighted average shares · filed 2026-07-30
$42.55
derived: net income ÷ weighted average shares · filed 2026-07-30
2025-12-31$8.19
derived: net income ÷ weighted average shares · filed 2026-04-24
$22.30
derived: net income ÷ weighted average shares · filed 2026-04-24
$35.56
derived: net income ÷ weighted average shares · filed 2026-07-30
$43.07
10-K · filed 2026-02-04
2025-09-30$14.09
10-Q · filed 2025-10-28
$27.33
derived: net income ÷ weighted average shares · filed 2026-07-30
$34.83
10-Q · filed 2025-10-28
$43.29
derived: net income ÷ weighted average shares · filed 2026-07-30
2025-06-30$13.24
10-Q · filed 2026-07-30
$20.78
10-Q · filed 2026-07-30
$29.29
derived: net income ÷ weighted average shares · filed 2026-07-30
$41.72
derived: net income ÷ weighted average shares · filed 2026-07-30
2025-03-31$7.58
10-Q · filed 2026-04-29
$16.11
derived: net income ÷ weighted average shares · filed 2026-07-30
$28.54
derived: net income ÷ weighted average shares · filed 2026-07-30
$41.81
derived: net income ÷ weighted average shares · filed 2026-07-30
2024-12-31$8.53
derived: net income ÷ weighted average shares · filed 2026-04-24
$20.94
derived: net income ÷ weighted average shares · filed 2026-04-24
$34.19
derived: net income ÷ weighted average shares · filed 2026-04-24
$40.90
10-K · filed 2026-02-04
2024-09-30$12.40
10-Q · filed 2025-10-28
$25.65
derived: net income ÷ weighted average shares · filed 2025-10-28
$32.36
10-Q · filed 2025-10-28
$43.26
derived: net income ÷ weighted average shares · filed 2026-04-24
2024-06-30$13.25
10-Q · filed 2025-08-01
$19.95
10-Q · filed 2025-08-01
$30.85
derived: net income ÷ weighted average shares · filed 2026-04-24
$40.33
derived: net income ÷ weighted average shares · filed 2026-04-24
2024-03-31$6.70
10-Q · filed 2025-04-29
$17.57
derived: net income ÷ weighted average shares · filed 2026-04-24
$27.05
derived: net income ÷ weighted average shares · filed 2026-04-24
$36.10
derived: net income ÷ weighted average shares · filed 2026-04-24
2023-12-31$10.90
derived: net income ÷ weighted average shares · filed 2026-04-24
$20.38
derived: net income ÷ weighted average shares · filed 2026-04-24
$29.43
derived: net income ÷ weighted average shares · filed 2026-04-24
$37.05
10-K · filed 2026-02-04
2023-09-30$9.48
10-Q · filed 2024-10-31
$18.53
derived: net income ÷ weighted average shares · filed 2024-10-31
$26.16
10-Q · filed 2024-10-31
$37.37
derived: net income ÷ weighted average shares · filed 2026-04-24
2023-06-30$9.05
10-Q · filed 2024-08-01
$16.69
10-Q · filed 2024-08-01
$27.89
derived: net income ÷ weighted average shares · filed 2026-04-24
$40.20
derived: net income ÷ weighted average shares · filed 2026-04-24
2023-03-31$7.64
10-Q · filed 2024-05-02
$18.84
derived: net income ÷ weighted average shares · filed 2026-04-24
$31.15
derived: net income ÷ weighted average shares · filed 2026-04-24
$39.03
derived: net income ÷ weighted average shares · filed 2026-04-24
2022-12-31$11.21
derived: net income ÷ weighted average shares · filed 2026-04-24
$23.52
derived: net income ÷ weighted average shares · filed 2026-04-24
$31.39
derived: net income ÷ weighted average shares · filed 2026-04-24
$40.51
10-K · filed 2025-02-05
2022-09-30$12.31
10-Q · filed 2023-11-02
$20.18
derived: net income ÷ weighted average shares · filed 2023-11-02
$29.30
10-Q · filed 2023-11-02
$50.20
derived: net income ÷ weighted average shares · filed 2026-04-24
2022-06-30$7.90
10-Q · filed 2023-08-03
$17.01
10-Q · filed 2023-08-03
$37.89
derived: net income ÷ weighted average shares · filed 2026-04-24
$53.25
derived: net income ÷ weighted average shares · filed 2026-04-24
2022-03-31$9.12
10-Q · filed 2023-05-04
$30.06
derived: net income ÷ weighted average shares · filed 2026-04-24
$45.42
derived: net income ÷ weighted average shares · filed 2026-04-24
$74.79
derived: net income ÷ weighted average shares · filed 2026-04-24
2021-12-31$20.97
derived: net income ÷ weighted average shares · filed 2026-04-24
$36.34
derived: net income ÷ weighted average shares · filed 2026-04-24
$65.76
derived: net income ÷ weighted average shares · filed 2026-04-24
$76.40
10-K · filed 2024-02-05
2021-09-30$15.37
10-Q · filed 2022-11-03
$44.80
derived: net income ÷ weighted average shares · filed 2022-11-03
$55.42
10-Q · filed 2022-11-03
$66.29
derived: net income ÷ weighted average shares · filed 2023-02-06
2021-06-30$29.51
10-Q · filed 2022-08-03
$40.06
10-Q · filed 2022-08-03
$50.93
derived: net income ÷ weighted average shares · filed 2023-02-06
$58.90
derived: net income ÷ weighted average shares · filed 2023-02-06
2021-03-31$10.58
10-Q · filed 2022-05-04
$21.47
derived: net income ÷ weighted average shares · filed 2023-02-06
$29.45
derived: net income ÷ weighted average shares · filed 2023-02-06
$37.59
derived: net income ÷ weighted average shares · filed 2023-02-06
2020-12-31$10.90
10-K · filed 2021-02-08
$18.87
derived: net income ÷ weighted average shares · filed 2023-02-06
$27.03
derived: net income ÷ weighted average shares · filed 2023-02-06
$32.65
10-K · filed 2023-02-06
2020-09-30$7.98
10-Q · filed 2021-11-04
$16.17
derived: net income ÷ weighted average shares · filed 2021-11-04
$21.83
10-Q · filed 2021-11-04
$29.08
derived: net income ÷ weighted average shares · filed 2022-02-07
2020-06-30$8.19
10-Q · filed 2021-08-05
$13.87
10-Q · filed 2021-08-05
$21.13
derived: net income ÷ weighted average shares · filed 2022-02-07
$27.25
derived: net income ÷ weighted average shares · filed 2022-02-07
2020-03-31$5.69
10-Q · filed 2021-05-06
$12.94
derived: net income ÷ weighted average shares · filed 2022-02-07
$19.06
derived: net income ÷ weighted average shares · filed 2022-02-07
$20.83
derived: net income ÷ weighted average shares · filed 2022-02-07
2019-12-31$7.25
10-K · filed 2021-02-08
$13.37
derived: net income ÷ weighted average shares · filed 2022-02-07
$15.14
derived: net income ÷ weighted average shares · filed 2022-02-07
$19.38
10-K · filed 2022-02-07
2019-09-30$6.12
10-K · filed 2021-02-08
$7.89
derived: net income ÷ weighted average shares · filed 2021-02-08
$12.12
10-Q · filed 2020-11-05
$19.69
derived: net income ÷ weighted average shares · filed 2021-02-08
2019-06-30$1.77
10-K · filed 2021-02-08
$6.00
10-Q · filed 2020-08-05
$13.56
derived: net income ÷ weighted average shares · filed 2021-02-08
$19.06
derived: net income ÷ weighted average shares · filed 2021-02-08
2019-03-31$4.23
10-K · filed 2021-02-08
$11.81
derived: net income ÷ weighted average shares · filed 2021-02-08
$17.31
derived: net income ÷ weighted average shares · filed 2021-02-08
$22.43
derived: net income ÷ weighted average shares · filed 2021-02-08
2018-12-31$7.58
10-K · filed 2020-02-07
$13.09
derived: net income ÷ weighted average shares · filed 2021-02-08
$18.21
derived: net income ÷ weighted average shares · filed 2021-02-08
$22.65
10-K · filed 2021-02-08
2018-09-30$5.50
10-K · filed 2020-02-07
$10.62
derived: net income ÷ weighted average shares · filed 2020-02-07
$15.06
10-Q · filed 2019-11-05
$16.71
derived: net income ÷ weighted average shares · filed 2020-02-07
2018-06-30$5.12
10-K · filed 2020-02-07
$9.56
10-Q · filed 2019-08-06
$11.20
derived: net income ÷ weighted average shares · filed 2020-02-07
$14.84
derived: net income ÷ weighted average shares · filed 2020-02-07
2018-03-31$4.44
10-K · filed 2020-02-07
$6.08
derived: net income ÷ weighted average shares · filed 2020-02-07
$9.71
derived: net income ÷ weighted average shares · filed 2020-02-07
$13.37
derived: net income ÷ weighted average shares · filed 2020-02-07
2017-12-31$1.62
10-K · filed 2019-02-07
$5.26
derived: net income ÷ weighted average shares · filed 2020-02-07
$8.91
derived: net income ÷ weighted average shares · filed 2020-02-07
$11.27
10-K · filed 2020-02-07
2017-09-30$3.64
10-K · filed 2019-02-07
$7.30
derived: net income ÷ weighted average shares · filed 2019-02-07
$9.66
10-Q · filed 2018-11-06
$12.08
derived: net income ÷ weighted average shares · filed 2019-02-07
2017-06-30$3.66
10-K · filed 2019-02-07
$6.02
10-Q · filed 2018-08-02
$8.43
derived: net income ÷ weighted average shares · filed 2019-02-07
$10.96
derived: net income ÷ weighted average shares · filed 2019-02-07
2017-03-31$2.36
10-K · filed 2019-02-07
$4.77
derived: net income ÷ weighted average shares · filed 2019-02-07
$7.29
derived: net income ÷ weighted average shares · filed 2019-02-07
$9.17
derived: net income ÷ weighted average shares · filed 2019-02-07
2016-12-31$2.41
10-K · filed 2018-02-08
$4.94
derived: net income ÷ weighted average shares · filed 2019-02-07
$6.81
derived: net income ÷ weighted average shares · filed 2019-02-07
$8.55
10-K · filed 2019-02-07
2016-09-30$2.53
10-K · filed 2018-02-08
$4.40
derived: net income ÷ weighted average shares · filed 2018-02-08
$6.14
10-Q · filed 2017-11-08
$7.64
derived: net income ÷ weighted average shares · filed 2018-02-08
2016-06-30$1.88
10-K · filed 2018-02-08
$3.61
10-Q · filed 2017-08-03
$5.11
derived: net income ÷ weighted average shares · filed 2018-02-08
$7.14
derived: net income ÷ weighted average shares · filed 2018-02-08
2016-03-31$1.74
10-K · filed 2018-02-08
$1.59
10-Q · filed 2016-05-05
$3.23
derived: net income ÷ weighted average shares · filed 2018-02-08
$5.27
derived: net income ÷ weighted average shares · filed 2018-02-08
$7.16
derived: net income ÷ weighted average shares · filed 2018-02-08
2015-12-31$1.49
10-K · filed 2017-02-09
$3.53
derived: net income ÷ weighted average shares · filed 2018-02-08
$5.42
derived: net income ÷ weighted average shares · filed 2018-02-08
$6.17
10-K · filed 2018-02-08
2015-09-30$2.04
10-K · filed 2017-02-09
$3.93
derived: net income ÷ weighted average shares · filed 2017-02-09
$4.68
10-Q · filed 2016-11-04
$5.57
derived: net income ÷ weighted average shares · filed 2017-02-09
2015-06-30$1.89
10-K · filed 2017-02-09
$2.64
10-Q · filed 2016-08-04
$3.53
derived: net income ÷ weighted average shares · filed 2017-02-09
$4.36
derived: net income ÷ weighted average shares · filed 2017-02-09
2015-03-31$0.74
10-K · filed 2017-02-09
$1.63
derived: net income ÷ weighted average shares · filed 2017-02-09
$2.46
derived: net income ÷ weighted average shares · filed 2017-02-09
$3.42
derived: net income ÷ weighted average shares · filed 2017-02-09
2014-12-31$0.89
10-K · filed 2016-02-11
$1.09
10-K · filed 2015-02-12
$1.72
derived: net income ÷ weighted average shares · filed 2017-02-09
$2.67
derived: net income ÷ weighted average shares · filed 2017-02-09
$3.36
10-K · filed 2017-02-09
$3.46
10-K · filed 2015-02-12
2014-09-30$0.83
10-K · filed 2016-02-11
$0.79
10-Q · filed 2014-11-04
$1.79
derived: net income ÷ weighted average shares · filed 2016-02-11
$2.47
10-Q · filed 2015-11-04
$2.37
10-Q · filed 2014-11-04
$3.46
derived: net income ÷ weighted average shares · filed 2016-02-11
2014-06-30$0.96
10-K · filed 2016-02-11
$0.92
10-Q · filed 2014-08-05
$1.65
10-Q · filed 2015-08-04
$1.58
10-Q · filed 2014-08-05
$2.63
derived: net income ÷ weighted average shares · filed 2016-02-11
$4.07
derived: net income ÷ weighted average shares · filed 2016-02-11
2014-03-31$0.69
10-K · filed 2016-02-11
$0.66
10-Q · filed 2014-05-08
$1.67
derived: net income ÷ weighted average shares · filed 2016-02-11
$3.11
derived: net income ÷ weighted average shares · filed 2016-02-11
$4.00
derived: net income ÷ weighted average shares · filed 2016-02-11
2013-12-31$0.98
10-K · filed 2015-02-12
$2.42
derived: net income ÷ weighted average shares · filed 2016-02-11
$3.31
derived: net income ÷ weighted average shares · filed 2016-02-11
$4.23
10-K · filed 2016-02-11
$4.33
10-K · filed 2014-02-13
2013-09-30$1.44
10-K · filed 2015-02-12
$2.33
derived: net income ÷ weighted average shares · filed 2015-02-12
$3.36
10-Q · filed 2014-11-04
$8.22
derived: net income ÷ weighted average shares · filed 2015-02-12
2013-06-30$0.89
10-K · filed 2015-02-12
$1.91
10-Q · filed 2014-08-05
$6.79
derived: net income ÷ weighted average shares · filed 2015-02-12
$8.81
derived: net income ÷ weighted average shares · filed 2015-02-12
2013-03-31$1.02
10-K · filed 2015-02-12
$5.91
derived: net income ÷ weighted average shares · filed 2015-02-12
$7.94
derived: net income ÷ weighted average shares · filed 2015-02-12
$8.77
derived: net income ÷ weighted average shares · filed 2015-02-12
2012-12-31$4.92
10-K · filed 2014-02-13
$6.94
derived: net income ÷ weighted average shares · filed 2015-02-12
$7.77
derived: net income ÷ weighted average shares · filed 2015-02-12
$7.92
10-K · filed 2015-02-12
2012-09-30$2.02
10-K · filed 2014-02-13
$2.83
derived: net income ÷ weighted average shares · filed 2014-02-13
$2.97
10-Q · filed 2013-11-05
$2.42
derived: net income ÷ weighted average shares · filed 2014-02-13
2012-06-30$0.81
10-K · filed 2014-02-13
$0.94
10-Q · filed 2013-08-06
$0.37
derived: net income ÷ weighted average shares · filed 2014-02-13
-$0.30
derived: net income ÷ weighted average shares · filed 2014-02-13
2012-03-31$0.12
10-K · filed 2014-02-13
-$0.45
derived: net income ÷ weighted average shares · filed 2014-02-13
-$1.13
derived: net income ÷ weighted average shares · filed 2014-02-13
-$1.82
derived: net income ÷ weighted average shares · filed 2014-02-13
2011-12-31-$0.58
derived: net income ÷ weighted average shares · filed 2014-02-13
-$1.27
derived: net income ÷ weighted average shares · filed 2014-02-13
-$1.96
derived: net income ÷ weighted average shares · filed 2014-02-13
-$2.45
10-K · filed 2014-02-13
2011-09-30-$0.68
10-Q · filed 2012-10-24
-$1.38
derived: net income ÷ weighted average shares · filed 2013-02-15
-$1.87
10-Q · filed 2012-10-24
2011-06-30-$0.69
10-Q · filed 2012-07-25
-$1.18
10-Q · filed 2012-07-25
2011-03-31-$0.49
10-Q · filed 2012-04-26
2010-12-31-$1.26
10-K · filed 2013-02-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07